Pending Bill Would Expand FTC Powers Over Drug Patent Settlements and Alter the Legal Test

February 14, 2013

The recent U.S. Senate bill would expand FTC powers and alter the legal test governing drug patent settlements. See Preserve Access to Affordable Generics Act, S. 214, 113th Cong., 1st Sess. (2013). This bill is the most recent iteration of such legislation, and, aside from updated data, it mirrors bills introduced in 2009 and 2011. See S. 27, 112th Cong., 1st Sess. (2011); S. 369, 111th Cong., 1st Sess. (2009).

Read “Pending Bill Would Expand FTC Powers Over Drug Patent Settlements and Alter the Legal Test.”